ImmuneScore As a Novel RNA-based Prognostic Signature Superior to PD-L1 in Advanced Non-Squamous NSCLC Patients Receiving Chemotherapy Combined with Immune Checkpoint Inhibitor Therapy
JOURNAL OF CANCER METASTASIS AND TREATMENT（2024）
Key words
Non-squamous non-small cell lung cancer,immune checkpoint inhibitors,RNA-based signature,ImmuneScore
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined